Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nasal Spray Market by Type (Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others), By Application (Asthma, COPD, Allergic Rhinitis, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nasal Spray Market by Type (Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others), By Application (Asthma, COPD, Allergic Rhinitis, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 133770 3300 Pharma & Healthcare 377 240 Pages 4.7 (38)

Market Overview:

The global nasal spray market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing awareness about the benefits of using nasal sprays, and technological advancements in nasal spray devices. The global nasal spray market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into corticosteroids, bronchodilators, combinations, decongestant sprays, and others. The corticosteroid segment is expected to dominate the global nasal spray market during the forecast period owing to its high efficacy in treating respiratory diseases such as asthma and COPD.

Global Nasal Spray Industry Outlook

Product Definition:

A nasal spray is a device that dispenses medication into the nose in a fine mist. It is used to relieve congestion, allergies, and colds.


Corticosteroids are naturally occurring hormones that are found in the adrenal glands. Corticosteroid drugs include a variety of topical creams, gels, ointments, solutions and sprays used to reduce inflammation or redness caused by skin conditions like eczema or psoriasis. Corticosteroids can also be administered through injections into the vein ( intravenous corticosteroid drug delivery system) or they can be taken by mouth as tablets or capsules.


Bronchodilators are drugs that widen the airways and increase the flow of air in to lungs. They work by relaxing smooth muscles in the bronchi of lungs, which reduces resistance to airflow. This allows more oxygen to get into blood cells and helps fight respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other lung disorders.

Application Insights:

The other application segment includes the treatment of snoring, nasal congestion and sinusitis. The COPD segment held the largest market share in 2017 owing to a rise in prevalence of chronic bronchitis and emphysema. According to estimates reported by the CDC, around 30 million adults have COPD which is expected to increase with aging as well as due to smoking tobacco. Thus, increasing incidence of COPD is expected fuel demand for nasal sprays in near future.

On the other hand, asthma held a significant market share in 2017 owing to high incidence coupled with prevalence of this disease across all age groups and both genders globally. According an article published by Global Asthma Report Card 2018 states that around 463 million people were affected by asthma worldwide which was an increase from 2016 when 420 million people were registered globally having this condition (asthma).

Regional Analysis:

North America dominated the global market in 2017. The presence of a large number of key players and increased adoption of advanced products for treatment options are some factors driving the regional market. In addition, high healthcare expenditure and favorable reimbursement policies are also expected to drive growth during the forecast period.

Asia Pacific is anticipated to witness significant growth over the forecast period owing to rising disposable income, increasing population base with various health conditions, improving healthcare infrastructure along with growing awareness about nasal sprays among patients is expected to drive demand for nasal spray drugs in this region over next eight years.

Growth Factors:

  • Increasing incidence of respiratory diseases: The global nasal spray market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
  • Technological advancements: The development of novel technologies for nasal sprays is expected to drive the growth of this market during the forecast period. For instance, in 2017, GlaxoSmithKline plc (GSK) launched its Ellipta dry powder inhaler that can be used with its Advair Diskus and Serevent Diskus products for the treatment of asthma and COPD. This product offers a new option for patients who are looking for an alternative to metered-dose inhalers (MDIs).
  • Rising awareness about preventive measures: There has been an increase in awareness among people about preventive measures against respiratory diseases such as asthma and COPD, which is driving demand for nasal sprays globally. In addition, governments are also promoting awareness programs about these diseases through various campaigns and initiatives, thereby propelling growth prospects for this market during the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Nasal Spray Market Research Report

By Type

Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others

By Application

Asthma, COPD, Allergic Rhinitis, Other

By Companies

Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy), Nephron Pharma, Beximco Pharma, Hikma (Roxane), XIANJU PHARMA

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Nasal Spray Market Report Segments:

The global Nasal Spray market is segmented on the basis of:


Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Asthma, COPD, Allergic Rhinitis, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Teva
  2. Sandoz (Novartis AG)
  3. Mylan
  4. Allergan PLC
  5. Cipla
  6. Akorn
  7. Apotex
  8. Sun Pharma (Ranbaxy)
  9. Nephron Pharma
  10. Beximco Pharma
  11. Hikma (Roxane)

Global Nasal Spray Market Overview

Highlights of The Nasal Spray Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Corticosteroids
    2. Bronchodilators
    3. Combinations
    4. Decongestant Sprays
    5. Others
  1. By Application:

    1. Asthma
    2. COPD
    3. Allergic Rhinitis
    4. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nasal Spray Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nasal Spray Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Nasal spray is a medication that is used to treat allergies, colds, and other respiratory infections. It comes in a variety of forms, including inhalers and nasal sprays. Nasal spray is usually effective when taken as soon as symptoms start.

Some of the major players in the nasal spray market are Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy), Nephron Pharma, Beximco Pharma, Hikma (Roxane), XIANJU PHARMA.

The nasal spray market is expected to grow at a compound annual growth rate of 5.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Nasal Spray Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Nasal Spray Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Nasal Spray Market - Supply Chain
   4.5. Global Nasal Spray Market Forecast
      4.5.1. Nasal Spray Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Nasal Spray Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Nasal Spray Market Absolute $ Opportunity

5. Global Nasal Spray Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Nasal Spray Market Size and Volume Forecast by Type
      5.3.1. Corticosteroids
      5.3.2. Bronchodilators
      5.3.3. Combinations
      5.3.4. Decongestant Sprays
      5.3.5. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Nasal Spray Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Nasal Spray Market Size and Volume Forecast by Application
      6.3.1. Asthma
      6.3.2. COPD
      6.3.3. Allergic Rhinitis
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Nasal Spray Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Nasal Spray Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Nasal Spray Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Nasal Spray Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Nasal Spray Demand Share Forecast, 2019-2029

9. North America Nasal Spray Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Nasal Spray Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Nasal Spray Market Size and Volume Forecast by Application
      9.4.1. Asthma
      9.4.2. COPD
      9.4.3. Allergic Rhinitis
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Nasal Spray Market Size and Volume Forecast by Type
      9.7.1. Corticosteroids
      9.7.2. Bronchodilators
      9.7.3. Combinations
      9.7.4. Decongestant Sprays
      9.7.5. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Nasal Spray Demand Share Forecast, 2019-2029

10. Latin America Nasal Spray Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Nasal Spray Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Nasal Spray Market Size and Volume Forecast by Application
      10.4.1. Asthma
      10.4.2. COPD
      10.4.3. Allergic Rhinitis
      10.4.4. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Nasal Spray Market Size and Volume Forecast by Type
      10.7.1. Corticosteroids
      10.7.2. Bronchodilators
      10.7.3. Combinations
      10.7.4. Decongestant Sprays
      10.7.5. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Nasal Spray Demand Share Forecast, 2019-2029

11. Europe Nasal Spray Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Nasal Spray Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Nasal Spray Market Size and Volume Forecast by Application
      11.4.1. Asthma
      11.4.2. COPD
      11.4.3. Allergic Rhinitis
      11.4.4. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Nasal Spray Market Size and Volume Forecast by Type
      11.7.1. Corticosteroids
      11.7.2. Bronchodilators
      11.7.3. Combinations
      11.7.4. Decongestant Sprays
      11.7.5. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Nasal Spray Demand Share, 2019-2029

12. Asia Pacific Nasal Spray Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Nasal Spray Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Nasal Spray Market Size and Volume Forecast by Application
      12.4.1. Asthma
      12.4.2. COPD
      12.4.3. Allergic Rhinitis
      12.4.4. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Nasal Spray Market Size and Volume Forecast by Type
      12.7.1. Corticosteroids
      12.7.2. Bronchodilators
      12.7.3. Combinations
      12.7.4. Decongestant Sprays
      12.7.5. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Nasal Spray Demand Share, 2019-2029

13. Middle East & Africa Nasal Spray Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Nasal Spray Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Nasal Spray Market Size and Volume Forecast by Application
      13.4.1. Asthma
      13.4.2. COPD
      13.4.3. Allergic Rhinitis
      13.4.4. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Nasal Spray Market Size and Volume Forecast by Type
      13.7.1. Corticosteroids
      13.7.2. Bronchodilators
      13.7.3. Combinations
      13.7.4. Decongestant Sprays
      13.7.5. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Nasal Spray Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Nasal Spray Market: Market Share Analysis
   14.2. Nasal Spray Distributors and Customers
   14.3. Nasal Spray Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Teva Overview Financials Developments Strategic Outlook
      14.4.2. Sandoz (Novartis AG) Overview Financials Developments Strategic Outlook
      14.4.3. Mylan Overview Financials Developments Strategic Outlook
      14.4.4. Allergan PLC Overview Financials Developments Strategic Outlook
      14.4.5. Cipla Overview Financials Developments Strategic Outlook
      14.4.6. Akorn Overview Financials Developments Strategic Outlook
      14.4.7. Apotex Overview Financials Developments Strategic Outlook
      14.4.8. Sun Pharma (Ranbaxy) Overview Financials Developments Strategic Outlook
      14.4.9. Nephron Pharma Overview Financials Developments Strategic Outlook
      14.4.10. Beximco Pharma Overview Financials Developments Strategic Outlook
      14.4.11. Hikma (Roxane) Overview Financials Developments Strategic Outlook
      14.4.12. XIANJU PHARMA Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us